Author/Creator: Friedman, Gary S - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Friedman, Gary S

1. Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management. Issue 6 (17th May 2021)

Authors:: Sands, Bruce E; Colombel, Jean-Frédéric; Ha, Christina; Farnier, Michel; Armuzzi, Alessandro; Quirk, Daniel; Friedman, Gary S; Kwok, Kenneth; Salese, Leonardo; Su, Chinyu; Taub, Pam R
Journal:: Inflammatory bowel diseases
Issue:: Volume 27:Issue 6(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management. Issue 6 (1st September 2020)

Authors:: Sands, Bruce E; Colombel, Jean-Frédéric; Ha, Christina; Farnier, Michel; Armuzzi, Alessandro; Quirk, Daniel; Friedman, Gary S; Kwok, Kenneth; Salese, Leonardo; Su, Chinyu; Taub, Pam R
Journal:: Inflammatory bowel diseases
Issue:: Volume 27:Issue 6(2021)
Page Start:: 797
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. PTU-001 Tofacitinib, an oral jak inhibitor, in the treatment of ulcerative colitis: open-label, long-term extension study. (8th June 2018)

Authors:: Bloom, Stuart; Lichtenstein, Gary R; Loftus, Edward V; Lawendy, Nervin; Friedman, Gary S; Zhang, Haiying; Wang, Wenjin; Thorpe, Andrew J; Nduaka, Chudy I; Su, Chinyu
Journal:: Gut
Issue:: Volume 67(2018)Supplement 1
Page Start:: A62
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis. (14th February 2019)

Authors:: Sands, Bruce E; Cheifetz, Adam S; Nduaka, Chudy I; Quirk, Daniel; Wang, Wenjin; Maller, Eric; Friedman, Gary S; Su, Chinyu; Higgins, Peter D R
Journal:: Journal of Crohn's and colitis
Issue:: Volume 13:Number 9(2019)
Page Start:: 1217
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme. (27th November 2020)

Authors:: Winthrop, Kevin L; Loftus, Edward V; Baumgart, Daniel C; Reinisch, Walter; Nduaka, Chudy I; Lawendy, Nervin; Chan, Gary; Mundayat, Rajiv; Friedman, Gary S; Salese, Leonardo; Thorpe, Andrew J; Su, Chinyu
Journal:: Journal of Crohn's and colitis
Issue:: Volume 15:Number 6(2021)
Page Start:: 914
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program. Issue 2 (1st February 2022)

Authors:: Sands, Bruce E; Long, Millie D; Reinisch, Walter; Panés, Julian; Loftus, Edward V; Nduaka, Chudy I; Soonasra, Arif; Mundayat, Rajiv; Lawendy, Nervin; Chan, Gary; Friedman, Gary S; Su, Chinyu
Journal:: Inflammatory bowel diseases
Issue:: Volume 28:Issue 2(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program. Issue 2 (20th March 2021)

Authors:: Sands, Bruce E; Long, Millie D; Reinisch, Walter; Panés, Julian; Loftus, Edward V; Nduaka, Chudy I; Soonasra, Arif; Mundayat, Rajiv; Lawendy, Nervin; Chan, Gary; Friedman, Gary S; Su, Chinyu
Journal:: Inflammatory bowel diseases
Issue:: Volume 28:Issue 2(2022)
Page Start:: 234
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗